Targeted protein degradation (TPD) is getting a lot of attention as a promising modality to treat a variety of diseases from ...

A University of North Florida biology professor was awarded a $720,000 grant from the National Institute of Health to fund a ...

The longevity of plant flowers is controlled by genetically programmed mechanisms. After a certain amount of time after ...

The compounds Everlastin1 and Everlastin2, which inhibit the binding of the transcription factor EPHEMERAL1 (EPH1), a ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a "protein ...

Johnson & Johnson today announced Lynne Maquat, Ph.D., of the University of Rochester, and Alexander Varshavsky, Ph.D., of the California Institute of Technology, as the winners of the 2024 Dr. Paul ...

The research team aimed to understand the degradation patterns of proteins to more quickly identify the bacteria involved and assess the risk of sepsis. The rise of antibiotic resistance has also ...

Lynne Maquat, Ph.D., and Alexander Varshavsky, Ph.D., to receive 2024 Dr. Paul Janssen Award for their fundamental discoveries about regulated degradation of RNA and proteins. NEW BRUNSWICK ...

Molecule sends 13 of the 17 most common forms of this cancer-related protein to the cell’s garbage-disposal system ...

Discover C4 Therapeutics' groundbreaking patent for BRD9-degrading compounds, targeting disorders like synovial sarcoma. Explore innovative treatments for better outcomes!